Atea Pharmaceuticals, Inc.
(AVIR - NASDAQ)
5,36 USD
📋 Profilo Aziendale

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections.

|